Frances is Principal Veterinary-Scientist and works translational medicine at Celevity. She works with the scientific leadership team to design and coordinate preclinical and clinical studies for experimental therapeutics, establish collaborative relationships with veterinary clinical and research experts, and aligns experimental plans to meet regulatory requirements for FDA’s Center of Veterinary Medicine. Frances is a graduate from Cornell University College of Veterinary Medicine’s Combined Degree DVM/PhD program; her integrated research and veterinary clinical training merged Cornell’s strengths as an exceptional graduate research institution with clinical training from one of the top veterinary schools in the nation. During her DVM/PhD, Frances was the first student from Cornell to obtain an NIH Ruth Kirchstein-NRSA F30 fellowship for clinician-scientist training. Frances completed her PhD in the lab of Natasza Kurpios in 2018, where she used CRISPR/Cas9 genome editing to generate a novel mutant mouse model for atrial arrhythmias by targeting noncoding elements at a genomic locus implicated in atrial fibrillation. During her veterinary training she pursued particular interests in canine genetics and behavior by working with canine genomics researchers at Embark Veterinary and the Working Dog Project at the Broad Institute. Frances completed her clinical training and graduated from the DVM curriculum in 2020, where she was awarded the Finger Lakes Kennel Club Prize for her decade of volunteer leadership and puppy raising activities with Guiding Eyes for the Blind and the Leonard Pearson Prize, nominated by the Dean of the College to a graduating Doctor of Veterinary Medicine with high academic achievement and potential for leadership in veterinary medicine.